Results 161 to 170 of about 17,683 (178)

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

Ophthalmology, 2022
Shienal Patel, Daniel Miller, Shrirang Ranade   +2 more
exaly  

Levodopa Is Associated with Reduced Development of Neovascular Age-Related Macular Degeneration

Ophthalmology Retina, 2023
Jeremy Lavine, Brian S Mckay, Nick Boucher   +2 more
exaly  

Experimental Models in Neovascular Age Related Macular Degeneration

International Journal of Molecular Sciences, 2020
Maeva Dufies
exaly  

Neovascular Age-Related Macular Degeneration and the Risk of Stroke

Stroke, 2010
Henry Lin, Chao-Chien Hu, Jau–Der Ho   +2 more
exaly  

Neovascular Age-Related Macular Degeneration

2006
ADAM H. ROGERS, ANDRE WITKIN
openaire   +1 more source

<p>Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration</p>

Clinical Ophthalmology, 2019
K Bailey Freund, Nicolas A Yannuzzi
exaly  

Incidence of Macular Atrophy after Untreated Neovascular Age-Related Macular Degeneration

Ophthalmology, 2020
John Campbell, Tiarnán Keenan, Elvira Agron   +2 more
exaly  

Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration

Ophthalmology, 2016
Daniel Martin, Ebenezer Daniel, Cynthia Tóth   +2 more
exaly  

The Controversial Role of TGF-β in Neovascular Age-Related Macular Degeneration Pathogenesis

International Journal of Molecular Sciences, 2018
Gian Marco Tôsi, Maurizio Orlandini, Federico Galvagni   +2 more
exaly  

Neovascular Age-Related Macular Degeneration

2016
Reinhard Told, Sebastian M. Waldstein, Ursula Schmidt-Erfurth   +2 more
openaire   +1 more source